30 September 2024
ProBiotix Health plc
("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")
Total Voting Rights
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, announces that the Company has 158,166,666 ordinary shares of 0.05p each in issue ("Ordinary Shares"), each share carrying the right to one vote.
This figure of 158,166,666 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
| ProBiotix Health plc | |
| Steen Andersen, Chief Executive Officer |
|
| | |
| Peterhouse Capital Limited Aquis Corporate Adviser And Broker | Tel: 020 7220 9793 |
| Mark Anwyl
| |
| Walbrook PR Ltd Anna Dunphy
| Mob: 07876 741 001
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
